Evidence map›Paper›PMID 41692519›Full record

Observational studyBMJ open2026

Dyspnoea patterns in patients with advanced diseases: a functional MRI feasibility study protocol.

Jan Gaertner, Lisa Hentsch, Ivan Guerreiro, Oliver A Kannape, Mathias Delahaye, Federica Bianchi, Chloe Cantero, Sophie Pautex, Anne Bergeron, Karl-Olof Lovblad and 2 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07319039 (Breathlessness Patterns in Patients With Cancer, COPD and Heart Failure), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07319039 recruitingnot on this map

Breathlessness Patterns in Patients With Cancer, COPD and Heart Failure: an fMRI Feasibility Study

TypeobservationalSponsorUniversity Hospital, GenevaRan2025 to 2027Enrolled16ConditionsChronic Obstructive Pulmonary Disease (COPD), Heart Failure, Cancer, VolunteersArmsCerebral fMRI, Immersive virtual reality
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jan GaertnerPalliative Care Center, Bethesda Spital AG, Basel, Switzerland jan.gaertner@unibas.ch.
Lisa HentschDivision of Palliative Medicine, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.
Ivan GuerreiroDivision of Pneumology, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Oliver A KannapeVirtual Medicine Centre, HUG-NeuroCentre, Department of Clinical Neurosciences, Geneva University Hospitals, Geneva, Switzerland.
Mathias DelahayeVirtual Medicine Centre, HUG-NeuroCentre, Department of Clinical Neurosciences, Geneva University Hospitals, Geneva, Switzerland.
Federica BianchiDivision of Palliative Medicine, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.
Chloe CanteroDivision of Pneumology, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Sophie PautexDivision of Palliative Medicine, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.
Anne BergeronFaculty of Medicine, University of Geneva, Geneva, Switzerland.
Karl-Olof LovbladFaculty of Medicine, University of Geneva, Geneva, Switzerland.
Felix Tobias KurzFaculty of Medicine, University of Geneva, Geneva, Switzerland.
Tanja Fusi-SchmidhauserFaculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-6270-1035

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDyspnoea is an existentially burdensome symptom in patients with advanced and progressive diseases such as cancer, chronic obstructive pulmonary disease (COPD) and advanced heart failure. Recent studies have highlighted that symptomatic treatment of dyspnoea is often ineffective and may depend on the underlying disease. Immersive virtual reality (IVR) has emerged as a 'digital therapeutic' for conditions such as pain, anxiety, and dyspnoea. Brain functional MRI (fMRI) offers the opportunity to identify distinct patterns of dyspnoea. Current findings are mainly limited to healthy volunteers, but clinical data from patients with life-limiting conditions are needed. The aim of this study is to assess the feasibility of identifying dyspnoea patterns in different life-limiting conditions using fMRI and IVR. METHODS AND ANALYSIS: This is an observational monocentric feasibility study, conducted in a tertiary university centre. Healthy volunteers and patients diagnosed with advanced cancer, COPD, or heart failure and suffering from persistent dyspnoea will undergo an fMRI of the brain using IVR. The primary outcome of feasibility will be evaluated using descriptive statistics. Secondary outcomes include analysis of fMRI patterns of dyspnoea across populations, patient-reported burden of participation, and correlation between dyspnoea and psychological symptoms. These preliminary data will help determine the sample size required for a future study evaluating differences in dyspnoea patterns. Exploratory comparison between the characteristics of all four groups will be assessed with Fisher's test (for proportions) and either independent Student's t-test or Mann-Whitney test, depending on distribution. Correlations between variables will be tested using the Pearson's correlation coefficient. Statistical analysis will be performed using STATA. ETHICS AND DISSEMINATION: This study protocol received ethical approval on 23 April 2025 from the TRIAL REGISTRATION NUMBER: Clinical Trials number is NCT07319039; Pre-results.

Indexed as

BrainDyspneaHeart FailureMagnetic Resonance ImagingNeoplasmsPulmonary Disease, Chronic ObstructiveAdultFeasibility StudiesFemaleHumansMaleResearch DesignCancerChronic DiseaseHeart failurePALLIATIVE CAREPulmonary Disease, Chronic Obstructive

Identifiers

PMID41692519
PMCPMC12911684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.